Virksomheder › GENMAB A/S
GENMAB A/S
CVR 21023884Carl Jacobsens Vej 30, 2500 Valby
Telefon 70202728E-mail info@genmab.com
Økonomisk overblik
Alle beløb i 1.000 kr.
Årets resultat og egenkapital
Seneste 5 regnskabsår · beløb i 1.000 kr.
Virksomheder › GENMAB A/S
Carl Jacobsens Vej 30, 2500 Valby
Telefon 70202728E-mail info@genmab.com
Alle beløb i 1.000 kr.
Seneste 5 regnskabsår · beløb i 1.000 kr.
Antal ansatte pr. regnskabsår
Antal ansatte pr. år. Hul i data: 2010 — linjen er bevidst brudt, ikke tegnet til nul.
| Navn | Rolle | Periode |
|---|---|---|
| Anthony Michael Pagano | Direktør | 01.03.2020 – nu |
| Pernille Lyngvold Erenbjerg | Næstformand | 26.03.2020 – nu |
| Elizabeth Grimes O’Farrell | Bestyrelse | 29.03.2022 – nu |
| Martin Schultz | Bestyrelse | 29.03.2022 – nu |
| Mijke Zachariasse | Bestyrelse | 22.03.2019 – nu |
| Paolo Augusto Paoletti | Bestyrelse | 26.03.2015 – nu |
| Rolf Karl Heinz Hoffmann | Bestyrelse | 28.03.2017 – nu |
| Artisan Partners Ltd. Partnership | REGISTRERET | — – nu |
| BLACKROCK, INC. | REGISTRERET | — – nu |
| Darwin Global Management Limited | REGISTRERET | — – nu |
| FMR LLC (Fidelity Management and Research) | REGISTRERET | — – nu |
| GlaxoSmithKline plc | REGISTRERET | — – nu |
| Jan van de Winkel | ADM. DIR. | 15.06.2010 – nu |
| Johnson & Johnson Innovation-JJDC, Inc. | REGISTRERET | — – nu |
| Martha Theresa Ramirez-Andersen | SUPPLEANT | 12.03.2025 – nu |
| Ogi Takahashi | SUPPLEANT | 12.03.2025 – nu |
| Société Générale S.A. | REGISTRERET | — – nu |
| Wellington Management Group LLP | REGISTRERET | — – nu |
| Navn | Rolle | Periode |
|---|---|---|
| GORRISSEN FEDERSPIEL KOMPLEMENTAR ADVOKATANPARTSSELSKAB | Stifter | 11.06.1998 – nu |
| DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Revisor | 13.03.2024 – nu |
| Arbejdsmarkedets Tillægspension | REGISTRERET | — – nu |
| DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | BÆREDYGTIGHEDSREVISION | 13.03.2024 – nu |
Rolle afsluttet: Michael Arthur Kavanagh — Bestyrelse
14.08.2026
Rolle afsluttet: Gina Theresa Schweizer — SUPPLEANT
14.08.2026
Slået op 25.10.2026 · Ansøgningsfrist 01.11.2026
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being
Slået op 25.10.2026 · Ansøgningsfrist 26.01.2027
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being
Slået op 23.10.2026 · Ansøgningsfrist 24.01.2027
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being